Abstract
Background Mothers of premature neonates often confront various psychological challenges including postpartum depression, anxiety, and elevated stress levels. However, anxiety has not received the necessary emphasis in routine clinical practice and research, often going unnoticed. There is insufficient data regarding the utilization of specific tools for screening maternal anxiety in hospitalized preterm infants. The study aimed to determine the prevalence of maternal anxiety and its risk factors among mothers of premature neonates admitted to the intensive care unit.
Methods Following Institutional Review Board (IRB) approval, a descriptive cross-sectional study was conducted at level-III Neonatal Unit, Fatima Memorial Hospital Shadman, Lahore over duration of 30 months, (January 2021-July 2023). Mothers werescreened for anxiety using Perinatal Anxiety Screening Scale (PASS) having 31 items. Comparative descriptive statistics and multiple logistic regression were applied to identify all risk factor while taking p <0.05 as significant.
Results Out of 430 mothers, 28.1% experienced anxiety. Statistically significant factors for maternal anxiety include young age, urban residence, higher education, smoking, diabetes, depression/anxiety diagnosis, primiparity, delivery complications, maternal involvement in neonatal care, breastfeeding, fear of handling preterm infants at home, and prematurity-related concerns, as well as gestational age, birth weight, and weight for gestational age (p < 0.05). Among all these, however, prematurity <28 weeks (p < 0.001, AOR 496, 95% CI 22.5–10951) and 28-31+6 weeks (p < 0.001, AOR 265, 95% CI 14– 5010), alongwith primiparity (p = 0.001, AOR 16.483, 95% CI 3.287–82.648), and SGA (p = 0.025, AOR 8.9, 95% CI 1.3–60.6) increase while extended family system protects from maternal anxiety (p = 0.002, AOR 0.25, 95% CI 0.106–0.595).
Conclusion Every third mother in our study population who delivered prematurely experienced anxiety. The younger gestational age, first-time motherhood, SGA neonate increase while the extended family system serves as a protective factor against maternal anxiety.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB Fatima Memorial Hospital, Shadman, Lahore, Pakistan IRB # FMH-12-2020-IRB-848-M
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
